Home Halogens N-(Cis-1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide

N-(Cis-1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide

CAS No.:
75272-39-8
Catalog Number:
AG008QLF
Molecular Formula:
C17H24N4O
Molecular Weight:
300.3987
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$105
- +
5mg
≥98%
1 week
United States
$215
- +
10mg
≥98%
1 week
United States
$300
- +
50mg
≥98%
1 week
United States
$1022
- +
Product Description
Catalog Number:
AG008QLF
Chemical Name:
N-(Cis-1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
CAS Number:
75272-39-8
Molecular Formula:
C17H24N4O
Molecular Weight:
300.3987
MDL Number:
MFCD00902138
IUPAC Name:
N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide
InChI:
InChI=1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)/t14-,18-/m1/s1
InChI Key:
KRVOJOCLBAAKSJ-RDTXWAMCSA-N
SMILES:
OC1CCCN(C1)CCCn1nc(nc1C)c1ccccc1
Properties
Complexity:
486  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
387.171g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
387.908g/mol
Monoisotopic Mass:
387.171g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
53.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.9  
Literature
Title Journal
Schizophrenia-like features in transgenic mice overexpressing human HO-1 in the astrocytic compartment. The Journal of neuroscience : the official journal of the Society for Neuroscience 20120808
Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway. The Journal of neuroscience : the official journal of the Society for Neuroscience 20110831
Dopamine D₁ and D₂ receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model: effect of serotonin, dopamine and norepinephrine. Neurological research 20101101
Dopamine D1 and D2 receptor functional down regulation in the cerebellum of hypoxic neonatal rats: neuroprotective role of glucose and oxygen, epinephrine resuscitation. Pharmacological research 20100201
[(3)H]-YM-09151-2 binding sites in human brain postmortem. Neurochemistry international 20091201
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. Behavioural brain research 20091105
Dopamine released by dendritic cells polarizes Th2 differentiation. International immunology 20090601
Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. The international journal of neuropsychopharmacology 20090201
A new entry into cis-3-amino-2-methylpyrrolidines via ring expansion of 2-(2-hydroxyethyl)-3-methylaziridines. Organic & biomolecular chemistry 20090107
3-Aminopyrrolidines from alpha-aminoacids: total synthesis of (+)-nemonapride from D-alanine. The Journal of organic chemistry 20080201
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation. Journal of neurochemistry 20070801
Catalytic asymmetric phase-transfer Michael reaction and Mannich-type reaction of glycine Schiff bases with tartrate-derived diammonium salts. Chemistry, an Asian journal 20070604
F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice. Naunyn-Schmiedeberg's archives of pharmacology 20070601
Presence of D4 dopamine receptors in human prefrontal cortex: a postmortem study. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20070601
Decreased [3H] YM-09151-2 binding to dopamine D2 receptors in the hypothalamus, brainstem and pancreatic islets of streptozotocin-induced diabetic rats. European journal of pharmacology 20070227
5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes. Clinical and experimental pharmacology & physiology 20070101
In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles. Naunyn-Schmiedeberg's archives of pharmacology 20060901
Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822. European journal of pharmacology 20060524
Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor. Molecular pharmacology 20060101
Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex. Pharmacology 20051001
Increased brain dopamine D4-like binding after chronic ethanol is not associated with behavioral sensitization in mice. Alcohol (Fayetteville, N.Y.) 20051001
Strain differences of dopamine receptor levels and dopamine related behaviors in rats. Brain research bulletin 20050430
Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia. Synapse (New York, N.Y.) 20041101
Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa 'knockout' mutants congenic on the C57BL/6 genetic background. The Journal of pharmacology and experimental therapeutics 20040901
Early adoption modifies the effects of prenatal stress on dopamine and glutamate receptors in adult rat brain. Journal of neuroscience research 20040515
The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter. Neuroscience research 20040301
SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography. European journal of pharmacology 20040223
Dopamine transmission in DYT1 dystonia. Advances in neurology 20040101
Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110. Pharmacological research 20031201
Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. Journal of neurochemistry 20031101
The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations. Experimental neurology 20031101
Characterization of dopamine D2 receptor gene expression and binding sites in human placenta amniotic epithelial cells. Placenta 20030701
Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands. Nuclear medicine and biology 20030501
Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys. Psychopharmacology 20030301
Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs. The Journal of pharmacology and experimental therapeutics 20030101
Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101
The impact of stereotactic pallidal surgery on the dopamine D2 receptor in Parkinson disease: a positron emission tomography study. Journal of neurosurgery 20030101
N-methyl-D-aspartate-R1 receptor antisense oligodeoxynucleotide modulates pre- and postsynaptic expression of D2 dopamine receptors in the rat. Neuroscience letters 20021219
Increased sensitivity in dopamine D(2)-like brain receptors from 2,4-dichlorophenoxyacetic acid (2,4-D)-exposed and amphetamine-challenged rats. Annals of the New York Academy of Sciences 20020601
Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart. Canadian journal of physiology and pharmacology 20020601
Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone. Nuclear medicine and biology 20020401
Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia. The Journal of pharmacology and experimental therapeutics 20020301
Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin. Progress in neuro-psychopharmacology & biological psychiatry 20020201
(-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors. European journal of pharmacology 20011207
Agonist-independent and -dependent oligomerization of dopamine D(2) receptors by fusion to fluorescent proteins. FEBS letters 20011019
Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum. Life sciences 20010803
The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients. Pharmacogenetics 20010801
No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study. Psychiatry research 20010214
Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine. Biochemical pharmacology 19951109
Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors. Neuroscience letters 19950217
Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse (New York, N.Y.) 19930801
Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats. Japanese journal of pharmacology 19870201
Properties